Neil W. Peterson, Chief Operating Officer of Merit Medical Systems Inc, filed a Form 4 on August 5, 2026, disclosing the sale of 21,449 shares of common stock on August 4, 2026.

Key Highlights

  • Shares sold: Peterson disposed of 21,449 shares of Merit Medical Systems common stock (no par value) on August 4, 2026.
  • Sale price: The shares were sold at $85 per share, according to the filing.
  • Remaining direct ownership: Following the transaction, Peterson directly holds 25,551 shares of common stock.
  • Stock options retained: Peterson continues to hold non-qualified stock options covering 25,000 shares (exercise price $68.33, expiring 08/19/2028) and 13,576 shares (exercise price $70.58, expiring 02/28/2030).
  • Issuer: Merit Medical Systems Inc, listed under the ticker MMSI.

Peterson's August 2026 Share Disposal and Remaining Holdings at Merit Medical

According to the Form 4 filed with the SEC on August 5, 2026, Neil W. Peterson, identified as Chief Operating Officer of Merit Medical Systems Inc (MMSI), reported a single open-market sale transaction. On August 4, 2026, Peterson disposed of 21,449 shares of Merit Medical common stock at a price of $85 per share, using transaction code "S." Following this disposition, the filing reports that Peterson directly holds 25,551 shares of the company's common stock.

In addition to the common stock position, the filing discloses two series of non-qualified stock options held directly by Peterson. The first covers 25,000 shares of common stock with an exercise price of $68.33, became exercisable beginning August 19, 2022 in equal annual installments of 25%, and expires August 19, 2028. The second covers 13,576 shares at an exercise price of $70.58, became exercisable beginning February 28, 2024 in equal annual installments of 25%, and expires February 28, 2030. The filing reports no changes to the derivative securities in this transaction.

The Form 4 was signed by Brian G. Lloyd as attorney-in-fact on behalf of Peterson and filed on August 5, 2026. The filing does not indicate that a Rule 10b5-1 trading plan was in place for this transaction, as the relevant checkbox was not checked.

What Was Disclosed

The filing reported the sale of 21,449 shares of Merit Medical Systems common stock by the company's Chief Operating Officer at $85 per share on August 4, 2026, leaving him with 25,551 directly held shares and two series of unexercised stock options.